SYNTHESIS OF ANTITUMOR AGENTS
抗肿瘤剂的合成
基本信息
- 批准号:2330762
- 负责人:
- 金额:$ 21.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-08-08 至 1999-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We propose to continue our efforts directed towards to==the synthesis of
polyketide marine natural products which exhibit notable anticancer
activities. The specific synthetic target molecules selected for the
proposed grant period are tedanolide (1), C32H52O11, isolated from
Caribbean sponge Tedania ignis, aplyronine (2), C54H92N2)12, from sea hare
Aplysia kurodai, and discodermolide (3), C33H55NO8, from the marine sponge
Discodermia dissoluta. Each of these marine products is a potent
anticancer agent possessing a unique structure. Tedanolide contains as
many as three acid-and base-sensitive beta-hydroxy moieties embedded in the
carbon framework, a feature rarely seen in other macrolide natural
products. Aplyronine exhibits striking biological activity as illustrated
by a 200-550% extension of the average lifetime of leukemic mice.
Aplyronine is a representative of structurally related compounds including
scytophycins, halichondramides, kabiramide and swinholides. Discodermolide
(3) not only inhibits the in vitro proliferation of murine P388 leukemia
cells, but has also been found to be an immunosuppressive agent ten times
as potent as cyclosporine. The relative simplicity of its structure is
another attractive feature and its synthesis may constitute a means of
providing substantial quantities of this compound for further biological
studies.
The proposed syntheses of 1-3 extensively use aldol reactions, the
stereochemical courses of which are governed by the rule of double
asymmetric synthesis. Thus, fragments of a target molecule are constructed
by single or multiple use of acetate or propionate additions to a selected
aldehyde with several chiral reagents now available. The coupling of
fragments involves a chiral aldehyde and a chiral ketone (both of which are
fragments) and is executed either (i) by the use of a third chiral
component which plays a stereochemically dominant role in the aldol
reaction or (ii) by exploiting certain types of structural features
existing in the reactants. The selection of chiral reagents to be used in
both the synthesis and coupling of fragments is a central theme of this
proposal.
我们建议继续努力,争取……的综合
具有显著抗癌作用的聚酮类海洋天然产物
活动。所选的特定合成目标分子
建议的授权期为tedanolide(1),C32H52O11,分离自
加勒比海绵Tedania Ignis,Aplyronine(2),C54H92N2)12,来自海兔
和盘状纤毛虫(Discodermolide)C33H55NO8
溶解盘皮病。这些海产品中的每一种都是一种强有力的
具有独特结构的抗癌剂。泰丹内酯含有AS
多达三个对酸和碱敏感的β-羟基嵌入在
碳骨架,这是其他天然大环内酯中罕见的特征
产品。如图所示,阿普利罗宁具有显著的生物活性
白血病小鼠的平均寿命延长了200-550%。
阿普利罗宁是结构上相关的化合物的代表,包括
镰刀菌素、灯盏花素、卡比拉胺和猪假日。米氏盘状物
(3)不仅抑制小鼠P388白血病细胞的体外增殖
细胞,但也被发现是一种十倍的免疫抑制剂
和环孢素一样有效。它的结构相对简单,是
另一个吸引人的特征及其合成可以构成一种手段
提供了大量的这种化合物用于进一步的生物
学习。
建议的1-3的合成广泛使用了Aldol反应,
其立体化学课程受双重规则支配
不对称合成。因此,构建了目标分子的片段
通过单次或多次使用醋酸酯或丙酸添加到选定的
乙醛和几种手性试剂现已上市。的耦合性
碎片涉及手性醛和手性酮(这两种物质都是
片段),并且(I)通过使用第三手性
在羟醛化合物中起立体化学主导作用的成分
反应或(Ii)通过利用某些类型的结构特征
存在于反应物中。手性试剂的选择
片段的合成和耦合都是这方面的一个中心主题
求婚。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATORU MASAMUNE其他文献
SATORU MASAMUNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATORU MASAMUNE', 18)}}的其他基金
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192205 - 财政年份:1988
- 资助金额:
$ 21.11万 - 项目类别:
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192203 - 财政年份:1988
- 资助金额:
$ 21.11万 - 项目类别:
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192200 - 财政年份:1988
- 资助金额:
$ 21.11万 - 项目类别:
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192204 - 财政年份:1988
- 资助金额:
$ 21.11万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 21.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 21.11万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 21.11万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 21.11万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 21.11万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 21.11万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 21.11万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 21.11万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 21.11万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 21.11万 - 项目类别: